arrow_back Trending Legislation
Share share

Ending Hidden Drug Fees: New Rules for Pharmacy Benefit Managers

This act aims to lower prescription drug costs for citizens by changing how Pharmacy Benefit Managers (PBMs) earn revenue. Starting in 2026, PBMs will only be allowed to charge flat service fees, preventing them from profiting from drug prices or rebates. This is intended to increase transparency and fairness in the drug market, potentially reducing out-of-pocket expenses for prescriptions.
Key points
PBMs will only be allowed to charge flat service fees, not based on drug prices or discounts, to prevent inflated costs.
Steering patients to PBM-owned pharmacies will be prohibited if it increases costs for the patient or health plan.
PBMs cannot charge health plans more for a drug's ingredient cost or dispensing fee than they reimburse pharmacies.
Violations will incur civil monetary penalties of $10,000 per day and require disgorgement of improperly received payments.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
DRUG Act
Print number: HR 6283
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]
Process start date: 2023-11-08
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Ending Hidden Drug Fees: New Rules for Pharmacy Benefit Managers

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 6283.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-11-08.

What are the main provisions?

Key points include:

  • PBMs will only be allowed to charge flat service fees, not based on drug prices or discounts, to prevent inflated costs.
  • Steering patients to PBM-owned pharmacies will be prohibited if it increases costs for the patient or health plan.
  • PBMs cannot charge health plans more for a drug's ingredient cost or dispensing fee than they reimburse pharmacies.
  • Violations will incur civil monetary penalties of $10,000 per day and require disgorgement of improperly received payments.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 6283

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health